Teladoc reports $1B net loss as it works to turn around its businessnews2025-02-27T15:25:56+00:00February 27th, 2025|Endpoints News|
Is the GLP-1 compounding boom over? Not exactlynews2025-02-25T15:34:25+00:00February 25th, 2025|Endpoints News|
Hims eyes growth in its weight loss business, despite end of semaglutide shortagenews2025-02-25T14:30:53+00:00February 25th, 2025|Endpoints News|
23andMe’s CEO submits bid to take company private for $74.7Mnews2025-02-24T16:35:50+00:00February 24th, 2025|Endpoints News|
Why UnitedHealth Group is offering 30,000 voluntary buyouts to its employeesnews2025-02-20T15:58:24+00:00February 20th, 2025|Endpoints News|
Hims buys at-home testing company Trybe Labsnews2025-02-19T21:24:53+00:00February 19th, 2025|Endpoints News|
What federal job cuts at HHS mean for health technews2025-02-18T17:43:25+00:00February 18th, 2025|Endpoints News|
